How Ponstan (Mefenamic Acid) Works
Mefenamic acid works primarily by inhibiting cyclooxygenase (COX) enzymes, particularly COX-2, which blocks prostaglandin synthesis responsible for pain, fever, and inflammation. 1
Mechanism of Action
Mefenamic acid operates through multiple complementary pathways that distinguish it from other NSAIDs:
Primary Mechanism: COX Inhibition
- Preferential COX-2 inhibition reduces prostaglandin synthesis at sites of inflammation, pain, and fever
- This blocks the conversion of arachidonic acid to prostaglandins (PGE2, PGF2α), which are key mediators of inflammatory responses 1
Additional Unique Mechanisms
Beyond standard NSAID activity, mefenamic acid has several distinctive properties:
E-type prostanoid (EP) receptor blockade: Directly antagonizes prostaglandin receptors, providing dual action by both reducing prostaglandin production AND blocking their effects 1
NLRP3 inflammasome inhibition: Suppresses this inflammatory pathway, enabling effectiveness against both inflammatory and non-inflammatory fevers 1
Enhanced platelet function: Improves platelet aggregation and degranulation, which contributes to its effectiveness in reducing menstrual blood loss by 30-50% through improved hemostasis 2
Clinical Effects
Antipyretic Action
- Produces rapid temperature reduction (mean time to normothermia: approximately 2 hours after first dose)
- Maintains sustained fever control for extended periods (average 62 hours) 3
- Superior antipyretic efficacy compared to paracetamol and ibuprofen in some contexts 1
Analgesic Action
- Particularly effective for dysmenorrhea: causes rapid, dramatic reductions in uterine pressure and contractile activity (complete loss of uterine contractions in 46% of patients) 4
- Reduces intrauterine pressure parameters and uterine work significantly 4
Anti-inflammatory Action
- Decreases menstrual blood loss by 40% through improved vasoconstriction and hemostatic plug formation 2
- Modest effect demonstrated for migraine prevention 5
Central Nervous System Effects
- Has cortical facilitatory effects, increasing amplitude of evoked responses in somatosensory cortex, suggesting central as well as peripheral actions 6
Important Clinical Considerations
Common pitfall: The drug label information provided 7 pertains to desmopressin acetate (for diabetes insipidus), NOT mefenamic acid, and should be disregarded for this question.
The fenamate class (which includes mefenamic acid) possesses unique biochemical properties that differentiate it from other NSAIDs, making it particularly suitable for pain syndromes and gynecological disorders 8. Recent evidence supports its expanding role in pediatric fever management with demonstrated safety when used appropriately 1, 3.